Table 1 Active metabolites predicted to be lowered in Jurkat cells
From: Identification of metabolites with anticancer properties by computational metabolomics
Previously known anticancer activity in Jurkat cells |
|---|
thymidine (C00214)1 |
prostaglandin D2 (C00696) |
Anticancer activity in Jurkat cells tested in this work |
riboflavin (C00255) |
tryptamine (C00398) |
3-sulfino-L-alanine (C00606) |
menaquinone (C00828) |
dehydroepiandrosterone sulfate (C04555) |
α-hydroxy fatty acid (C05102) |
hydroxyacetone (C05235) |
seleno-L-methionine (C05335) |
α-ribazole (C05775) |